PMD patient-derived iPSCs and their gene corrected line for disease mechanisms
| Title | PMD patient-derived iPSCs and their gene corrected line for disease mechanisms |
|---|---|
| Acronym | PMD |
| Start date | 2014-10-01 |
| End date | |
| Sponsor | National Multiple Sclerosis Society |
| Institution | SAFE iPS Facility - Institute for stem cell biology & regenerative medicine |
Associated cell lines
Project Description
This study uses patient-derived iPSCs and their gene corrected isogenic control lines to study mechanisms of PMD.